Menu

Home / For Visitors / 2024 Exhibitor List / BOYEN THERAPEUTICS, INC.

BOYEN THERAPEUTICS, INC.

Area: Pharmaceutical and Medical Devices

Booth No: L126

Website: http://www.boyentherapeutics.com/

Exhibitor Profile

BoYen Therapeutics Inc. has a proprietary prodrug platform that enables chemosynthesis modifications to create patentable new drug candidates, for treatment of new indications. Our pipeline comes with immense commercial values. Currently, two candidates are under development. BY-101 is an USFDA designated orphan drug with a 7-year marketing exclusivity; it is intended for the treatment of acute myeloid leukemia (AML). BYT-1007 is patented drug candidate for the treatment of multiple sclerosis.

Exhibitors you may be interested in

Highest Rated

TOP